Pharmacodynamic and pharmacokinetic studies in rats of S-8-(2-furyl)- and R-8-phenyl-2-(di-n-propylamino)tetralin, two novel 5-HT(1A) receptor agonists in-vitro with different properties in-vivo

Journal of Pharmacy and Pharmacology

Volumn 49, Issue 2, 1997, Pages 169-177

  Yu, Hong ^a   Liu, Ye ^a   Li, Hong B ^b   Martin, Arnold R ^b   Hacksell, Uli ^a   Lewander, Tommy ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN; SEROTONIN 1A RECEPTOR; TETRALIN DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; HYPOTHERMIA; MALE; NONHUMAN; PHARMACODYNAMICS; RAT;

EID: 0031051918     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1997.tb06774.x     Document Type: Article

References (31)

1. Arvidsson, L. E., Hacksell, U., Nilsson, J. L. G., Hjorth, S., Carlsson, A., Lindberg, P., Sanchez, D., Wikström, H. (1981) 8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist. J. Med. Chem. 24: 921-923
2. Artigas, F. (1995) 5-Hydroxytryptamine and antidepressant augmentation. Arch. Gen. Psychiatry 52: 969-971
3. 1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino) tetralin-induced effects. J. Pharmacol. Exp. Ther. 258: 58-65
4. Blier, P., De Montigny, C. (1994) Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 15: 220-226
5. 1A receptors in the dorsal raphe and hippocampus: I. Effect of spiperone. J. Pharmacol. Exp. Ther. 265: 7-15
6. Boess, F. G., Martin, I. L. (1994) Molecular biology of 5-HT receptors. Neuropharmacology 33: 275-317
7. Carlsson, A., Davis, J. N., Kehr, W., Lindqvist, M., Atack, C. V. (1972) Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase. Naunyn Schmiedebergs Arch. Pharmacol. 275: 153-168
8. 1A receptors that are negatively coupled to adenylate cyclase. Mol. Pharmacol. 39: 780-787
9. 1A receptor-mediated inhibition of forskolin-stimulated adenylyl cyclase activity in guinea-pig and rat hippocampal membranes. J. Pharmacol. Exp. Ther. 238: 248-253
10. 1A receptor agonists: recent developments and controversial issues. Psychopharmacology 121: 1-26
11. 1A receptor antagonist. Br. J. Pharmacol. 112: 92P
12. 1A receptor antagonist, WAY-100635. Eur. J. Pharmacol. 281: 81-88
13. 1A receptor function in the rat in vivo. Eur. J. Pharmacol. 191: 391-400
14. 2-receptor affinity. J. Pharm. Pharmacol. 43: 481-485
15. 1A-receptor agonists and antagonists. Drug Des. Discov. 9: 287-297
16. 1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in-vivo. Naunyn Schmiedebergs Arch Pharmacol. 338: 463-471
17. Hjorth, S., Carlsson, A., Lindberg, P., Sanchez, D., Wikström, H., Arvidsson, L. E., Hacksell, U., Nilsson, J. L. G. (1982) 8-Hydroxy-2-di-n-propylaminotetralin, 8-OH-DPAT, a potent and selective simple ergot congener with 5-HT-receptor stimulating activity. J. Neural Transm. 55: 1690-1188
18. 1A agonist properties of the novel stereoselective 8-OH-DPAT analogue (+)cis-8-hydroxy-1-methyl-2-(di-n-propylamino) tetralin, (+)ALK-3. Eur. J. Pharmacol. 170: 269-274
19. Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., Humphrey, P. P. A. (1994) International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46: 157-203
20. 1A receptors. J. Med. Chem. 36: 4221-4229
21. 1A-receptors. Eur. J. Med. Chem. 30: 277-286
22. Manners, C. N., Payling, D. W., Smith, D. A. (1988) Distribution coefficient, a convenient term for the relation of predictable physicochemical properties to metabolic processes. Xenobiotica 18: 331-350
23. 1A agonists. Mol. Pharmacol. 37: 231-237
24. 3H)8-hydroxydipropylaminotetralin. J. Neurochem. 62: 1822-1834
25. Pardridge, W. M., Oldendorf, W. H. (1977) Transport of metabolic substrates through the blood-brain barrier. J. Neurochem. 28: 5-12
26. Peroutka, S. J. (1994) Molecular biology of serotonin (5-HT) receptors. Synapse 210: 88-90
27. Ruetz, S., Gros, P. (1994) A mechanism for P-glycoprotein action in multidrug resistance: are we there yet? Trends Pharmacol. Sci. 15: 260
28. Sharp, T., Bramwell, S. R., Hjorth, S., Grahame-Smith, D. G. (1989) Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis. Br. J. Pharmacol. 98: 989-997
29. Temple, D. L. (1995) Antidepressants: clinical and neuropharmacologic considerations relevant to future drug discovery and development. Exp. Opin. Invest. Drugs 4: 909-914
30. Tsuji, A., Tamai, I., Sakata, A., Tenda, Y., Terasaki, T. (1993) Restricted transport of cyclosporin A across the blood-brain-barrier by a multidrug transporter, P-glycoprotein. Biochem. Pharmacol. 46: 1096-1099
31. Yu, H., Lewander, T. (1997) Pharmacodynamic and pharmacokinetic studies of R-8-hydroxy-2-(di-n-propylamino)tetralin in the rat. Eur Neuropsychopharmacol. In press